Ryan MacDonald: Got it. Okay. That’s helpful. And then in terms of as you look to continue to build out these new businesses or these new offerings, what sort of incremental investments need to be made, if any, on sort of go-to-market motion there? And then as you contemplate sort of the $500 million target, what potential do you believe there is for these new offerings to accelerate your path to that $500 million? .
Chaim Indig: Let’s just take what we like our commitment. We feel really good about it. One point, in front of the other for now. Look, I think one of the reasons why we also wanted to be very clear to talk about this opportunity to our investors is we have been making a lot of investments in it, and we think it’s our responsibility to articulate where some of those investments have gone. And I think that’s the compact we have with our shareholders. And so once it got to a certain, like, size and we started talking about it, we thought it was just the right thing to do, right, is to — and we’re pretty excited about it, and we’re in market talking to a lot of early clients about it, and they’re pretty happy. So we thought this was the right platform and forum to properly articulate this. And we’ll be talking about it more over the coming years as it grows.
Balaji Gandhi: And we do think it’s going to be a big part of us getting to where we have committed to being in the coming years.
Ryan MacDonald: Understood. Thanks for the color and congrats again.
Balaji Gandhi: Well, thanks, Ryan.
Operator: Your next question comes from the line of Jack Wallace with Guggenheim. Your line is now open.
Unidentified Participant: Hi. This is actually Sandy on for Jack. Obviously, a lot of the questions have been asked and answered. But maybe just one, and I think I maybe know the answer because you’re enthusiastic across all the business lines. But when I look at the lift in revenue guidance and how you’ve been bringing that up through the year, against my model at least or Jack’s model, the network solutions, new innings has been the one that’s really outperformed this quarter. But is there any certain area you’d call out or do you just generally more positive across all three of the segments?
Chaim Indig: We’re pretty positive about all three of the segments. Look, payments was a little bit lighter than we thought it would be when we started the year. And I think we’ve been articulating that it could go up and it could go down throughout the year, depending on flu season and if people are going to the visits or not. But I think the team is just — look, there’s a bunch of variability that when you start the year, you plan for the worse than you hope for the best. So I think that’s one of the things. And continuously, we try to figure out how something good happens, how we do more of it. And if something bad happens, and we prevent it from happening over and over again. And for 18 years, we would run the business, and it’s a lot of work and you just pay attention to the details, and you surround yourself with as many amazing people as possible, and you empower them to just make a difference at every stage of the way.
And if you keep — if we keep doing that, as we have for the last 18 years or the next 18 years, we’re going to build a very significant company in health care. And we feel pretty good about that.
Unidentified Participant: Great. That’s really helpful. And then just a quick housekeeping. The number of FCRs in the quarter or at the end of the quarter?
Balaji Gandhi: The number is 175, including FCRs .
Unidentified Participant: Great. Okay. Thanks so much.
Chaim Indig: Thank you and give Jack our best if you talk to him.
